dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:29:35Z
dc.date.available2014-05-27T11:29:35Z
dc.date.created2014-05-27T11:29:35Z
dc.date.issued2013-06-01
dc.identifierBehavioural Pharmacology, v. 24, n. 3, p. 214-221, 2013.
dc.identifier0955-8810
dc.identifier1473-5849
dc.identifierhttp://hdl.handle.net/11449/75537
dc.identifier10.1097/FBP.0b013e3283618ae4
dc.identifierWOS:000318267400007
dc.identifier2-s2.0-84876996238
dc.identifier1117432571971568
dc.description.abstractThe bed nucleus of the stria terminalis (BNST) is a limbic structure that has a direct influence on the autonomic, neuroendocrine, and behavioral responses to stress. It was recently reported that reversible inactivation of synaptic transmission within this structure causes antidepressant-like effects, indicating that activation of the BNST during stressful situations would facilitate the development of behavioral changes related to the neurobiology of depression. Moreover, noradrenergic neurotransmission is abundant in the BNST and has an important role in the regulation of emotional processes related to the stress response. Thus, this study aimed to test the hypothesis that activation of adrenoceptors within the BNST facilitates the development of behavioral consequences of stress. To investigate this hypothesis, male Wistar rats were stressed (forced swimming, 15 min) and 24 h later received intra-BNST injections of vehicle, WB4101, RX821002, CGP20712, or ICI118,551, which are selective α1, α2, β1, and β2 adrenoceptor antagonists, respectively, 10 min before a 5-min forced swimming test. It was observed that administration of WB4101 (10 and 15 nmol), CGP20712 (5 and 10 nmol), or ICI118,551 (5 nmol) into the BNST reduced the immobility time of rats subjected to forced swimming test, indicating an antidepressant-like effect. These findings suggest that activation of α1, β1, and β2 adrenoceptors in the BNST could be involved in the development of the behavioral consequences of stress. © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins.
dc.languageeng
dc.relationBehavioural Pharmacology
dc.relation1.854
dc.relation0,916
dc.relation0,916
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectadrenoceptors
dc.subjectbed nucleus of the stria terminalis
dc.subjectforced swimming test
dc.subjectnoradrenaline
dc.subjectrat
dc.subjectstress
dc.subject2 (2 methoxy 1,4 benzodioxan 2 yl) 2 imidazoline
dc.subject2 [[2 (2,6 dimethoxyphenoxy)ethyl]aminomethyl] 1,4 benzodioxan
dc.subject3 isopropylamino 1 (7 methyl 4 indanyloxy) 2 butanol
dc.subject5 [2 [[2 hydroxy 3 [4 (1 methyl 4 trifluoromethyl 2 imidazolyl)phenoxy]propyl]amino]ethoxy]salicylamide
dc.subjectbeta 1 adrenergic receptor
dc.subjectbeta 2 adrenergic receptor
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectantidepressant activity
dc.subjectbehavior change
dc.subjectcontrolled study
dc.subjectimmobilization
dc.subjectlimbic system
dc.subjectlocomotion
dc.subjectmale
dc.subjectneurotransmission
dc.subjectnonhuman
dc.subjectnoradrenergic system
dc.subjectopen field test
dc.subjectstria terminalis
dc.titleNoradrenergic neurotransmission within the bed nucleus of the stria terminalis modulates the retention of immobility in the rat forced swimming test
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución